Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics

View ORCID ProfileMichał Różański, View ORCID ProfileAurelia Walczak-Drzewiecka, Jolanta Witaszewska, Ewelina Wójcik, Arkadiusz Guziński, Bogumił Zimoń, Rafał Matusiak, Joanna Kazimierczak, Maciej Borowiec, Katarzyna Kania, Edyta Paradowska, Jakub Pawełczyk, Jarosław Dziadek, Jarosław Dastych
doi: https://doi.org/10.1101/2021.05.06.21256733
Michał Różański
1Laboratory of Cellular Immunology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michał Różański
Aurelia Walczak-Drzewiecka
1Laboratory of Cellular Immunology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aurelia Walczak-Drzewiecka
Jolanta Witaszewska
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewelina Wójcik
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arkadiusz Guziński
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bogumił Zimoń
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafał Matusiak
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Kazimierczak
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maciej Borowiec
3Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarzyna Kania
4Laboratory of Virology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edyta Paradowska
4Laboratory of Virology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakub Pawełczyk
5Laboratory of Mycobacterium Genetics and Physiology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarosław Dziadek
5Laboratory of Mycobacterium Genetics and Physiology, Institute of Medical Biology of PAS, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarosław Dastych
1Laboratory of Cellular Immunology, Institute of Medical Biology of PAS, Lodz, Poland
2Proteon Pharmaceuticals S.A., Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jdastych@proteonpharma.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Swab, quantitative, reverse transcription polymerase chain reaction (RT-qPCR) tests remain the gold standard of diagnostics of SARS-CoV-2 infections. However, these tests are costly and time-consuming, and swabbing limits their throughput. We developed a 3-gene, seminested RT-qPCR test with SYBR green-based detection, optimized for testing pooled saliva samples for high-throughput diagnostics of epidemic-affected populations. The proposed two-tier approach depends on decentralized self-collection of saliva samples, pooling, 1st-tier testing with the mentioned highly sensitive screening test and subsequent 2nd-tier testing of individual samples from positive pools with the in vitro diagnostic (IVD) test. The screening test was able to detect 5 copies of the viral genome in 10 µl of isolated RNA with 50% probability and 18.8 copies with 95% probability and reached Ct values that were highly linearly RNA concentration-dependent. In the side-by-side comparison (testing artificial pooled samples), the screening test attained slightly better results than the commercially available IVD-certified RT-qPCR diagnostic test (100% specificity and 89.8% sensitivity vs. 100% and 73.5%, respectively). Testing of 1475 individual clinical samples pooled in 374 pools of 4 revealed 0.8% false positive pools and no false negative pools. In weekly prophylactic testing of 113 people within 6 months, a two-tier testing approach enabled the detection of 18 infected individuals, including several asymptomatic individuals, with a fraction of the costs of individual RT-PCR testing.

Competing Interest Statement

Jarosław Dastych is the CEO of Proteon Pharmaceuticals S.A., which offers the presented method as a commercial service.

Funding Statement

This work was funded by Proteon Pharmaceuticals S.A. and statutory funds of the Institute of Medical Biology of PAS

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The usage of anonymized samples from patients of the Center of Molecular Diagnostics of Pathogens, Proteon Pharmaceuticals S.A. in the study was approved by the Bioethical Committee at the University of Lodz (Res. nr 3/KBBN-UŁ/I/2020-21).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: This work was funded by Proteon Pharmaceuticals S.A. and statutory funds of the Institute of Medical Biology of PAS

  • Conflict of interest: Jarosław Dastych is the CEO of Proteon Pharmaceuticals S.A., which offers the presented method as a commercial service.

Data Availability

The authors confirm that the summarized data supporting the findings of this study are available within the article. The raw data are available from the corresponding author, Jarosław Dastych, upon reasonable request.

  • Abbreviations

    RT
    reverse transcriptase
    RT-qPCR
    quantitative reverse transcription polymerase chain reaction
    IVD
    in vitro diagnostics (certificate)
    dNTP
    deoxyribonucleotide triphosphate
    DEPC
    diethyl pyrocarbonate
    GAPDH
    glyceraldehyde 3-phosphate dehydrogenase
    Tm
    melting temperature
    Ct
    threshold cycle (in quantitative PCR)
    CI
    confidence interval
    HBSS
    Hanks’ balanced salt solution
    PPE
    personal protective equipment
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted May 09, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics
    Michał Różański, Aurelia Walczak-Drzewiecka, Jolanta Witaszewska, Ewelina Wójcik, Arkadiusz Guziński, Bogumił Zimoń, Rafał Matusiak, Joanna Kazimierczak, Maciej Borowiec, Katarzyna Kania, Edyta Paradowska, Jakub Pawełczyk, Jarosław Dziadek, Jarosław Dastych
    medRxiv 2021.05.06.21256733; doi: https://doi.org/10.1101/2021.05.06.21256733
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics
    Michał Różański, Aurelia Walczak-Drzewiecka, Jolanta Witaszewska, Ewelina Wójcik, Arkadiusz Guziński, Bogumił Zimoń, Rafał Matusiak, Joanna Kazimierczak, Maciej Borowiec, Katarzyna Kania, Edyta Paradowska, Jakub Pawełczyk, Jarosław Dziadek, Jarosław Dastych
    medRxiv 2021.05.06.21256733; doi: https://doi.org/10.1101/2021.05.06.21256733

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (161)
    • Allergy and Immunology (414)
    • Anesthesia (90)
    • Cardiovascular Medicine (857)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (248)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
    • Epidemiology (8557)
    • Forensic Medicine (4)
    • Gastroenterology (383)
    • Genetic and Genomic Medicine (1749)
    • Geriatric Medicine (167)
    • Health Economics (372)
    • Health Informatics (1239)
    • Health Policy (620)
    • Health Systems and Quality Improvement (467)
    • Hematology (196)
    • HIV/AIDS (372)
    • Infectious Diseases (except HIV/AIDS) (10292)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (211)
    • Neurology (1676)
    • Nursing (97)
    • Nutrition (249)
    • Obstetrics and Gynecology (326)
    • Occupational and Environmental Health (450)
    • Oncology (928)
    • Ophthalmology (263)
    • Orthopedics (101)
    • Otolaryngology (172)
    • Pain Medicine (112)
    • Palliative Medicine (40)
    • Pathology (252)
    • Pediatrics (534)
    • Pharmacology and Therapeutics (248)
    • Primary Care Research (207)
    • Psychiatry and Clinical Psychology (1765)
    • Public and Global Health (3835)
    • Radiology and Imaging (623)
    • Rehabilitation Medicine and Physical Therapy (320)
    • Respiratory Medicine (520)
    • Rheumatology (208)
    • Sexual and Reproductive Health (166)
    • Sports Medicine (158)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)